WealthStone’s ResMed RMD Stock Holding History

WealthStone’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-5	Closed	-$610	–	490
2019 Q2	$610	Buy	+5	New	+$554	﹤0.01%	793

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

WealthStone's RMD Position: Q3 2019 in Review

WealthStone sold out of ResMed (RMD) in Q3 2019, closing a stake of 5 shares — an estimated $610 sold.

WealthStone first reported a position in RMD in Q2 2019 and held it in 1 quarter. The position peaked at $610 in Q2 2019. 527 funds tracked by Wall St. Rank hold RMD as of Q3 2019.

WealthStone reported no remaining ResMed position as of Q3 2019 after selling out during the quarter.
WealthStone sold 5 ResMed shares in Q3 2019, an estimated $610.
WealthStone first reported a position in ResMed in Q2 2019 and held it in 1 quarter.
WealthStone's ResMed position peaked at $610 in Q2 2019.
527 funds tracked by Wall St. Rank held ResMed as of Q3 2019.

Based on WealthStone's 13F filing for Q3 2019, filed 15 Nov 2019.